ClinicalTrials.gg
CompletedNCT05081778DissobeUpdated Jul 17, 2026

Dissociative Disorders in Obesity (Dissobe)

An observational study in Obesity and Dissociative Disorder, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
240
Ages
18 Years and older
Sex
All
01

Study summary

THe aim of this study is to determine the frequency of dissociative tendencies in the obese population treated at the CELIOBE (Liberal Center for Obesity Support) at Hôpital Privé La Louvière among patients consulting for the first time and looking for a medical or surgical course. The DES scale of Carlson and Putman will be used.

02

Conditions studied

  • Obesity
  • Dissociative Disorder
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's enrollment of 240 is above the median of 114 across 2,154 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 207 studies on the registry; 99 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Obese population with a body mass index over 30kg/m2 Minimum age : 18 years-old Patients consulting for the first time at CELIOBE and wishing a medical or surgical course.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age over 18
  • Obesity defined by a (BMI) ≥ 30 kg / m2
  • Patient seen in consultation at CELIOBE for the first time for the management of an overweight problem, wishing for surgical or medical care
  • Patient having been informed and not opposing to this research
  • Patient affiliated or beneficiary of a social security scheme

Exclusion criteria

Exclusion Criteria:

  • Psychotic antecedents: Schizophrenia, Schizoaffective disorders, Hallucinatory psychoses, Brief psychotic attacks
  • Addictive behaviors (alcohol, drug addiction)
  • Drug use
  • Taking antipsychotics and mood stabilizers
  • Dissociative identity disorders proven
  • Bipolar disorders or severe mental illness
  • Understanding troubles
  • Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent
  • Pregnant, breastfeeding or parturient woman
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
240 participants (actual)
Patient registry
No

Groups and cohorts

  • Obese patient following a medical course

    Behavioral: Obese patient following a medical course

  • Obese patient following a surgical course

    Behavioral: Obese patient following a medical course

Interventions

  • BehavioralObese patient following a medical course

    Questionnaires for the assessment of dissociative disorders in obese patients : DES scale of Carlson and Putman, SDQ-20 of Nijenhuis, comorbidities, Dutch Eating Behaviour Questionnaire (DEBQ), questionnaire of Rosenberg

06

What researchers measure

Primary outcomes

  1. The degree of dissociative tendencies

    The degree of dissociative tendencies measured by the Carlson and Putman DES scale. Score from 0 to 100. Patients with a DES score of 25 or higher are more likely to have a dissociative disorder

    Time frame: 1 day

07

Study locations

1 site
  • Hôpital privé La Louvière
    Lille, Haut de France 59800, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2019 to primary completion in Jul 2019, 2 months.

Of 791 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's 2 months is below that.

Counting every sponsor, half of 836 studies reached it within 39 months; a quarter within 17 and three quarters within 96.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 4, 2021
First posted
Oct 18, 2021
StartActual
May 5, 2019
Primary completionActual
Jul 5, 2019
CompletionActual
Dec 5, 2019
Last update
Jul 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05081778
Collaborators
European Clinical Trial Experts Network
Responsible party
Sponsor
First posted
Oct 18, 2021
Start date
May 5, 2019
Primary completion
Jul 5, 2019
Completion
Dec 5, 2019
Last update
Jul 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion